Evidence map›Paper›PMID 36365478›Full record

ReviewPolymers2022

A Study on Doping and Compound of Zinc Oxide Photocatalysts.

Tan Mao, Mengchen Liu, Liyuan Lin, Youliang Cheng, Changqing Fang

Abstract readReview
In one paragraph

Review in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tan MaoCollege of Mechanical and Material Engineering, North China University of Technology, Beijing 100144, China.
Mengchen LiuCollege of Mechanical and Material Engineering, North China University of Technology, Beijing 100144, China.
Liyuan LinCollege of Mechanical and Material Engineering, North China University of Technology, Beijing 100144, China.
Youliang ChengCollege of Printing, Packaging and Digital Media, Xi'an University of Technology, Xi'an 710000, China.
Changqing FangCollege of Printing, Packaging and Digital Media, Xi'an University of Technology, Xi'an 710000, China.

Funding

Central Guidance on Local Science and Technology Development Fund of Shaanxi Province 2020-ZYYD-NCC-9Key Research and Development Plan of Shaanxi Province 2020GXLH-Z-031Key Scientific Research Project of Education Department of Shaanxi Province 20JS106Key Scientific Research Project of Weinan City 2020ZDYF-GYCX-107National Key Research and Development Program of China 2021YFD1600402National Natural Science Foundation of China 52072075Outstanding Youth Science Fund of Shaanxi Province 2018JC-028Science and technology planning project of Qindu District, Xianyang City 2021QKJ-001Shaanxi Provincial Department of Education Collaborative Innovation Center Project 20JY052
6 · The paper itself

Abstract

As an excellent semiconductor photocatalyst, zinc oxide is widely used in the field of photocatalysis and is regarded as one of the most reliable materials to solve environmental problems. However, because its band gap energy limits the absorption of visible light and reduces the efficiency of catalytic degradation, it needs to be doped with other substances or compounded with other substances and precious metal. This paper summarizes the research on this aspect at home and abroad in recent years, introduces the doping of transition metal ions by zinc oxide, the compounding of zinc oxide with precious metals or other semiconductors, and the prospect of further improving the catalytic efficiency of zno photocatalyst is also put forward.

Indexed as

compounddopingphotocatalysiszinc oxide

Identifiers

PMID36365478
PMCPMC9657537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.